FDA authorizes Intuitive's latest da Vinci system

• The FDA has approved Intuitive Surgical's (NASDAQ:ISRG) da Vinci Xi Surgical System, which the company says "has broader capabilities than prior generations" of the device.
• "It can be used across a wide spectrum of minimally invasive surgical procedures and has been optimized for complex, multi-quadrant surgeries," Intuitive says.
• The FDA's authorization comes amid reports of adverse events involving previous versions of the da Vanci and scores of lawsuits.
• Shares are +9.8%. (PR)